Extension of Phase 3 Gene Therapy for Painful Diabetic Neuropathy
Conditions: Painful Diabetic Neuropathy; Diabetic Neuropathy, Painful Interventions: Genetic: Long-Term Follow-Up of Patients who Received VM202; Drug: Long-Term Follow-Up of Patients who Received Placebo Sponsor: Helixmith Co., Ltd. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials